Sort by
Refine Your Search
-
Employer
- The University of Iowa
- Duke University
- University of Massachusetts Medical School
- CUNY School of Medicine
- New York University
- The Ohio State University
- The University of Chicago
- University of California, Los Angeles
- University of Colorado
- University of Miami
- University of Nebraska Medical Center
- University of Utah
- 2 more »
- « less
-
Field
-
University of Massachusetts Medical School | Worcester, Massachusetts | United States | 44 minutes ago
modeling, or machine learning - Experience with large-scale genomic data analysis (e.g., GWAS, QTL, PRS, or multi-omics integration) Strong programming skills in R or Python; familiarity with Bayesian
-
and manipulating complex data structures, Bayesian modeling, analyzing nested longitudinal data, and who are familiar with techniques for handling challenging data (e.g., highly non-normal distributions
-
. The Theranostics laboratory works on developing new radioligands for advanced malignancies. We are particularly interested in the preclinical development of new radioligands that can target therapy-resistant tumor
-
University of Massachusetts Medical School | Worcester, Massachusetts | United States | about 2 months ago
-target events and other genomic alterations potentially associated with genome editing. 3) The translation of the developed genome editing reagents to clinical application through in vivo safety and
-
the daily lives and functioning of the child and family in various settings such as home, school, and the community. Common challenging behaviors targeted in our clinical services include self-injury
-
, architecture, mechanics, and function. The work will involve generating gene-targeted mouse models and characterizing them through histological, biochemical, and molecular analyses. Successful completion
-
signaling—shapes the development and tissue targeting of autoimmune disease, and how anti-self responses arise in cancer. The long-term goal is to develop innovative therapies for conditions that currently
-
. - Develop and apply genome-wide screening strategies and protein-based tools to investigate disease mechanisms and therapeutic targets. - Collaborate with FGSR leadership and users to co-develop
-
. We also study lymphatic drainage pathways in the dura mater, aiming to understand how they influence CSF dynamics and whether they can be therapeutically targeted. Our team currently includes one
-
, metastasis, functional genomics, therapeutic target development, and cancer proteomics. Submit a full-length CV, a 3-page future research plan, and the names and contact for 3-5 references Required